Takeda's AI-powered "returning to growth" program has improved profit margins, leading to upgraded FY2024 guidance and a JPY100 billion share buyback program. Takeda's Rusfertide and Protagonist's ...

Takeda Nobutada is one of the challenging characters that is hard to master due to his extraordinary abilities. Players who know when to wait to strike can use their primary skill, Mythic Grab ...

The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. This week, the medicine, first approved in 2009, was listed as discontinued on the ...

Global biopharmaceutical company Takeda has launched an innovation capability centre (ICC) in Bengaluru, India, joining existing facilities in Slovakia and Mexico. The Bengaluru ICC will focus on ...

Takeda Pharmaceutical Company ( (TAK) ) has shared an update. Takeda Pharmaceutical Company has submitted an extraordinary report detailing its decision to dissolve its specified subsidiary, Shire ...

Following a series of layoff rounds this year, Takeda is once again pruning its headcount in the Bay State. Takeda is laying off dozens of employees in Massachusetts, according to a Worker ...

Nobutada Saji hails from a family with a long-standing legacy ... Takahisa Takahara is a name synonymous with the pharmaceutical industry in Japan. As the CEO and President of Takeda Pharmaceutical ...

Takeda has made some cuts to its clinical-phase pipeline, hacking off midphase programs and early-stage prospects as part of a push to focus on its most promising candidates. Let’s start in phase 2.

One of these characters is Takeda Nobutada, who is decent in Solo, but almost ubiquitous in Trios. “Takeda is very strong,” Tryhard explained. “I think he’s weakened a little bit in solos ...

Takeda’s vision of becoming a leader in oncology ran into more trouble Thursday when the drugmaker axed (PDF) a midphase immunocytokine and three early-stage CAR-T cell therapy prospects from ...

Following the engagement, which saw Nobunaga’s forces defeat those under Takeda Katsuyori, the former ... On the same day, Yasuke joined the forces of Oda Nobutada, the son of Nobunaga. Thomas Lockley ...

Takeda Pharmaceutical struck one of the biggest life science deals of 2022, acquiring a clinical-stage Nimbus Therapeutics drug addressing a promising new target for autoimmune disorders.